Increased GLP-1 response to oral glucose in pre-pubertal obese children.
View / Open Files
Authors
Giannini, Cosimo
Pietropaoli, Nicoletta
Polidori, Nella
Chiarelli, Francesco
Mohn, Angelika
Publication Date
2016-08-01Journal Title
Journal of Pediatric Endocrinology and Metabolism
ISSN
2191-0251
Publisher
De Gruyter
Volume
29
Issue
8
Pages
901-906
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Giannini, C., Pietropaoli, N., Polidori, N., Chiarelli, F., Marcovecchio, L., & Mohn, A. (2016). Increased GLP-1 response to oral glucose in pre-pubertal obese children.. Journal of Pediatric Endocrinology and Metabolism, 29 (8), 901-906. https://doi.org/10.1515/jpem-2016-0050
Abstract
BACKGROUND: Gastrointestinal hormones, such as glucagon-like peptide (GLP-1), have been hypothesized to play a role in the pathogenesis of obesity-related complications. However, few data are available in youth. The objective of this study was to investigate the GLP-1 response to oral glucose load in obese pre-pubertal children and its relationship with insulin secretion. METHODS: Ten pre-pubertal obese children [five boys; 10.5±1.6 years; body mass index-standard deviation score (BMI-SDS): 2.2±0.5] and 10 controls (eight boys; 9.9±1.2 years; BMI-SDS: -0.7±0.5) underwent a modified oral glucose tolerance test (OGTT) to evaluate post-load glucose, insulin and GLP-1 responses. Insulin sensitivity [homeostasis model assessment of insulin resistance (HOMA-IR), whole body insulin sensitivity index (WBISI)] and secretion [HOMA-beta, insulinogenic index (IGI)] indexes, area under the curve (AUC) for glucose, insulin and GLP-1 were calculated. RESULTS: In obese children GLP-1 AUC values were higher and correlated with BMI-SDS (r=0.45; p=0.04), HOMA-IR (r=0.53; p=0.01) and fasting glucose (r=0.68; p=0.001). CONCLUSIONS: Obese children showed an increased GLP-1 response to oral glucose. These changes might likely represent a compensatory mechanism to avoid post-prandial hyperglycemia and allow a normal glucose tolerance.
Keywords
Biomarkers, Case-Control Studies, Child, Female, Follow-Up Studies, Glucagon-Like Peptide 1, Glucose, Glucose Tolerance Test, Humans, Incretins, Male, Obesity, Prognosis, Puberty
Identifiers
External DOI: https://doi.org/10.1515/jpem-2016-0050
This record's URL: https://www.repository.cam.ac.uk/handle/1810/279002
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved